Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
Cash from Operating Activities
Abbott India Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Cash from Operating Activities
₹8.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Operating Activities
₹72.1B
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Operating Activities
₹37.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Operating Activities
₹121.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Operating Activities
₹37.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Operating Activities
₹29.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott India Ltd's Cash from Operating Activities?
Cash from Operating Activities
8.9B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Cash from Operating Activities amounts to 8.9B INR.
What is Abbott India Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
42%
Over the last year, the Cash from Operating Activities growth was -6%. The average annual Cash from Operating Activities growth rates for Abbott India Ltd have been 13% over the past three years , 42% over the past five years .